New mass spec test could spot lyme disease faster
NCT ID NCT02414789
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times
Summary
This study tested a new diagnostic method (mass spectrometry) to detect Lyme disease bacteria in skin biopsies from 84 people with early Lyme rash (erythema migrans). The new method was compared to standard PCR and culture tests. The goal was to see if the new technique could identify the bacteria more often than existing methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a faster, more accurate diagnostic test for early Lyme disease.
- What could go wrong
- This is a small, completed study testing a new method against existing ones. The new test may not prove more sensitive or practical for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHEMA MIGRANS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier William Morey
Chalon-sur-Saône, France
-
Centre Hospitalo-Universitaire Jean Minjoz
Besançon, France
-
Hôpital Bel Air
Thionville, France
-
Hôpital E. Muller
Mulhouse, France
-
Hôpital Pasteur
Colmar, France
-
Hôpital Robert Debré
Reims, France
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.